Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential vanilloid subfamily member 1 (TRPV1) is a non-selective cation channel primarily expressed in sensory neurons. It acts as a polymodal sensor, detecting noxious heat (>43°C), acidic conditions, capsaicin, and other chemical irritants. Activation leads to calcium influx and neuronal excitation, mediating pain sensation and contributing to thermoregulation and inflammation. TRPV1 is a tetrameric assembly of subunits, each with six transmembrane domains. It is an important therapeutic target for pain management disorders, though side effects remain a challenge for drug development.
Agonists activate the channel, leading to calcium influx and neuronal excitation. Antagonists block channel activation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential vanilloid subfamily member 1 (TRPV1).